Hypertension
Conditions
Keywords
Hypertension, Drug therapy, combination
Brief summary
To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.
Interventions
Previously untreated hypertensive adult patients starting with combination therapy containing nifedipine or insufficiently controlled hypertensive patients receiving nifedipine as an add-on to existing non-CCB containing antihypertensive therapy. The decision of including the patient as well as decision on dosage and duration is taken by the investigator.
Sponsors
Bayer
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Previously untreated hypertensive patients starting with combination therapy containing nifedipine or * Insufficiently controlled hypertensive pts. receiving nifedipine as an add-on to existing non-CCB (calcium-channel-blocker) containing antihypertensive therapy
Exclusion criteria
* None.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of treatment success (lowering of blood pressure in mmHg) in adult hypertensive patients | After three months |
Countries
Bahrain, Egypt, Jordan, Lebanon, Morocco, Oman, Pakistan, Qatar, Russia, Saudi Arabia, United Arab Emirates
Outcome results
None listed